October 10, 2019
A new Institute for Clinical and Economic Review report found drugmakers between 2017 and 2018 increased the prices of seven drugs without clinical evidence to justify the increases, costing patients and insurers more than $5 billion—but drugmakers are questioning the report's accuracy.
A Philadelphia jury on Tuesday ordered New Jersey-based Johnson & Johnson (J&J) to pay $8 billion in punitive damages to a Maryland man who claimed J&J failed to properly warn patients and providers that its antipsychotic drug Risperdal could spur breast growth in boys.
GlaxoSmithKline on Tuesday announced that it is recalling the common heartburn drug Zantac in all markets as a "precaution," after FDA last week announced that it has detected "unacceptable" levels of a cancer-causing chemical in some samples of the drug—but the recall will not affect Zantac products sold in the United States.
October 9, 2019
About 25% of U.S. health care spending annually is wasteful, according to a study published Monday in JAMA. See where all the money goes on our interactive charts.
CMS on Monday announced that it will add a new icon to its Nursing Home Compare website to alert consumers when a nursing home has been cited for incidents of abuse, neglect, or exploitation.
October 8, 2019
Medicare last week began the latest payment adjustments to hospitals under the Hospital Readmissions Reduction Program, and more than 2,500 hospitals will face penalties for fiscal year 2020, according to a Kaiser Health News analysis.
October 7, 2019
The Federal Trade Commission last month sent warning letters to seven law firms and marketing companies, warning that their ads seeking patients for personal injury lawsuits against drugmakers could violate federal law and cause patients to avoid taking their medications.
October 4, 2019
President Trump on Thursday issued an executive order that aims to expand private Medicare Advantage (MA) plans, more closely align Medicare fee-for-service payments with MA and commercial plans, and implement other Medicare reforms.
FDA this week announced that it has found "unacceptable levels" of the cancer-causing chemical it has detected in ranitidine drugs used to treat heartburn, including the common brand-name drug Zantac.
Walmart on Thursday announced that, starting next year, it will test a program in certain markets that will financially incentivize employees to use doctors the company has determined are higher-quality than other doctors in the area.
Advisory Board. All rights reserved.